This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
This introduction highlights common weighting schemes across major indices and why the chosen method affects performance interpretation.
4,019 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oklo stock popped today after a regulatory milestone signaled progress for the company’s Aurora fast-fission technolo...
Markets are rotating away from AI hype toward real, tangible assets. A small engineering firm is asserting itself wit...
The Federal Reserve kept the benchmark rate unchanged in a policy decision this week. Officials say fallout from wart...
Brent crude surged to $119, shaking nerves across the markets as energy names led gains while other sectors faced pre...
Tensions with Iran are driving a puzzling market mix: gold retreats while equities slip only modestly, hinting at a b...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...
BlackRock’s chief executive argues that AI’s biggest impact is on who owns wealth, not just who loses a job. Here’s h...
Policy makers and tech leaders converge to treat China as a shared risk in AI leadership, signaling potential shifts ...
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...